Can the Rituximab Dose Go Ultra-Low in RA?

06:00 EST 8 Nov 2019 | MedPageToday

(MedPage Today) -- A strategy of using ultra-low doses of rituximab (Rituxan, MabThera) as maintenance treatment for rheumatoid arthritis in patients who responded well to this B-cell depleting agent did not demonstrate non-inferiority in a randomized...

Original Article: Can the Rituximab Dose Go Ultra-Low in RA?


More From BioPortfolio on "Can the Rituximab Dose Go Ultra-Low in RA?"

Quick Search

Relevant Topics

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...